Setmelanotide Success for More Genetic Obesities; No Breast Cancer-Metformin Link
Recently approved setmelanotide (Imcivree) showed promise as a treatment for severe obesity arising from genetic variants in the MC4R pathway, Rhythm Pharmaceuticals announced. Overweight or obesity could be detrimental to brain health, potentially magnifying Alzheimer's disease. (The Journal of Alzheimer's Disease) A large study found no link between metformin and…
bubmagJanuary 31, 2021